Company / Current Liabilities per Share
Opus Genetics, Inc. Current Liabilities per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.25
FY2025
5-year range
$0.15 / $0.47
FY2021-FY2025
Trend
-47.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.19 to $0.25 over the past 2 years.
Based on SEC 10-K filings.
0.25 in FY2025 with a 3-year CAGR of +19.0%.
Increased from $0.19 to $0.25 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +19.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 47.7% year-over-year.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.25 | -47.7% |
| FY2024 | $0.47 | +143.1% |
| FY2023 | $0.19 | +32.6% |
| FY2022 | $0.15 | -58.8% |
| FY2021 | $0.35 | - |
| FY2013 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026